March 07, 2026 02:37 pm (IST)
Zydus Cadila receives USFDA approval to market Carboplatin Injection
Ahmedabad, Apr 1 (IBNS) Zydus Cadila, a fully integrated, global healthcare provider, announced on Friday that it has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Your cooking gas gets costlier: LPG prices rise across India amid Middle East crisis
Sat, Mar 07 2026
Mahindra's BE 6 Batman edition returns, check out the price
Fri, Mar 06 2026
Premium Finnish chocolates could soon hit Indian stores via Reliance. All details inside
Fri, Mar 06 2026
Major push: Tata Power collaborates with Salesforce to accelerate India’s clean energy transition
Fri, Mar 06 2026
Defence stock on fire! Mazagon Dock Shipbuilders Limited jumps 8% as massive Rs 99,000 crore deal nears approval
Fri, Mar 06 2026
